These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

561 related items for PubMed ID: 19263697

  • 1. Nephrogenic systemic fibrosis: is gadolinium to be blamed?
    Jikki PN.
    J Assoc Physicians India; 2008 Nov; 56():915-6. PubMed ID: 19263697
    [No Abstract] [Full Text] [Related]

  • 2. Focus on contrast-associated nephrogenic systemic fibrosis.
    Partain CL.
    J Magn Reson Imaging; 2009 Dec; 30(6):1231-2. PubMed ID: 19938033
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nephrogenic systemic fibrosis and gadolinium: a cautionary tale in the molecular imaging era.
    Wang SC.
    J Med Imaging Radiat Oncol; 2008 Aug; 52(4):305-6. PubMed ID: 18811752
    [No Abstract] [Full Text] [Related]

  • 5. Gadolinium and systemic fibrosis: guilt by association.
    Kay J, Czirják L.
    Ann Rheum Dis; 2010 Nov; 69(11):1895-7. PubMed ID: 20959325
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Nephrogenic systemic fibrosis developed after recovery from acute renal failure: gadolinium as a possible aetiological factor.
    Lu CF, Hsiao CH, Tjiu JW.
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):339-40. PubMed ID: 18573157
    [No Abstract] [Full Text] [Related]

  • 8. Gadolinium-based contrast agents and nephrogenic systemic fibrosis: why did it happen and what have we learned?
    Weinreb JC, Abu-Alfa AK.
    J Magn Reson Imaging; 2009 Dec; 30(6):1236-9. PubMed ID: 19938035
    [Abstract] [Full Text] [Related]

  • 9. Nephrogenic systemic fibrosis: possible mechanisms and imaging management strategies.
    Dawson P.
    J Magn Reson Imaging; 2008 Oct; 28(4):797-804. PubMed ID: 18821621
    [No Abstract] [Full Text] [Related]

  • 10. Nephrogenic systemic fibrosis: the need for accurate case reporting.
    Spinazzi A, Kirchin MA, Pirovano G.
    J Magn Reson Imaging; 2009 May; 29(5):1240; author reply 1241. PubMed ID: 19388104
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Renal failure and gadolinium. The number of documented cases is rising.
    Prescrire Int; 2008 Oct; 17(97):205. PubMed ID: 19537311
    [No Abstract] [Full Text] [Related]

  • 16. Pathomechanisms of nephrogenic systemic fibrosis: new insights.
    Gupta A, Shamseddin MK, Khaira A.
    Clin Exp Dermatol; 2011 Oct; 36(7):763-8. PubMed ID: 21790732
    [Abstract] [Full Text] [Related]

  • 17. Gadolinium-associated nephrogenic systemic fibrosis.
    Schlaudecker JD, Bernheisel CR.
    Am Fam Physician; 2009 Oct 01; 80(7):711-4. PubMed ID: 19817341
    [Abstract] [Full Text] [Related]

  • 18. Gadolinium and nephrogenic systemic fibrosis.
    Runge VM.
    AJR Am J Roentgenol; 2009 Apr 01; 192(4):W195-6; discussion W197. PubMed ID: 19304681
    [No Abstract] [Full Text] [Related]

  • 19. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
    Hamilton-Persaud K, Ezell LD, Macklin JG.
    Nephrol Nurs J; 2007 Apr 01; 34(3):283-7; quiz 288. PubMed ID: 17644872
    [Abstract] [Full Text] [Related]

  • 20. Nephrogenic systemic fibrosis and contrast medium-induced nephropathy: a choice between the devil and the deep blue sea for patients with reduced renal function?
    Lind Ramskov K, Thomsen HS.
    Acta Radiol; 2009 Nov 01; 50(9):965-7. PubMed ID: 19863403
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.